600666.SH
奥瑞德
SSE · Healthcare · Drug Manufacturers - General · CN
CNY 3.38
−2.87%Aug 17, 2026, 09:04 UTC
A court-ordered auction of shares held by a 5%+ shareholder of Aorui (Oriental) was completed, with Wei Wei and Wang Feiyan acquiring 60.8 million restricted shares, reducing the shareholder's stake to 3.98%.
Aug 10, 2026, 09:02 UTC
Taiji Group's controlling subsidiary Southwest Pharmaceutical received a drug registration certificate from the National Medical Products Administration for butorphanol tartrate injection, in specifications of 1ml:1mg and 2ml:4mg, for the treatment of cancer pain and postoperative pain.
Source: